Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023

Rhea-AI Summary

Evogene Ltd. will release its financial results for Q3 2023 on November 15, 2023. The company aims to revolutionize life-science product discovery and development. A conference call will be held on the same day at 9:00 AM ET to discuss the results. The call can be joined using the provided numbers. A replay of the call will be available for three days.

Conference call scheduled for 9:00 AM ET

REHOVOT, Israel, Nov. 2, 2023 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that it will release its financial results for the third quarter of 2023, on Wednesday, November 15, 2023.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference call, please use the following numbers: +1-888-281-1167 toll-free from the United States or +972-3-918-0609 internationally.

A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial +1-888-326-9310 toll-free from the United States or +972-3-925-5901 internationally. The telephone replay will be accessible for three days, but an archive of the webcast will be available from the webcast link for the following twelve months.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its five subsidiaries including:

1. Biomica Ltd. (www.biomicamed.com) developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
2. Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome based ag-biologicals powered by MicroBoost AI;
3. AgPlenus Ltd. (www.agplenus.com) -developing next generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
4. Canonic Ltd. (www.canonicbio.com) – developing medical cannabis products based on decoding plant genetics for optimized therapeutic effect powered by GeneRator AI; and
5. Casterra Ag Ltd. (www.casterra.co)– developing and marketing superior castor seed varieties producing high yield and high-grade oil content, on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Contacts

Rachel Pomerantz Gerber
Head of Investor Relations at Evogene
rachel.pomerantz@evogene.com
Tel: +972-8-9311901

Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2023-financial-results-release--conference-call-for-november-15-2023-301975609.html

SOURCE Evogene

FAQ

When will Evogene release its financial results for Q3 2023?

Evogene will release its financial results for Q3 2023 on November 15, 2023.

What is Evogene's main focus?

Evogene is a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments.

When is the conference call scheduled?

The conference call is scheduled for November 15, 2023, at 9:00 AM Eastern Time (4:00 PM Israel time).

How can I join the conference call?

To join the conference call, please use the following numbers: +1-888-281-1167 toll-free from the United States or +972-3-918-0609 internationally.

Will there be a replay of the conference call?

Yes, a replay of the conference call will be available approximately two hours after the call. To access the replay, dial +1-888-326-9310 toll-free from the United States or +972-3-925-5901 internationally.

How long will the telephone replay be accessible?

The telephone replay will be accessible for three days.

Will there be an archive of the webcast?

Yes, an archive of the webcast will be available from the webcast link for the following twelve months.